22 2010
5th International Conference on Marine Bioprospecting, Tromso, Norway
23-25th February 2011
Registration and preliminary program available in September
BIOPROSP is a leading international biennial conference series on bioprospecting from cold marine environments. These conferences aim to present explorative research and its industrial applications in an integrated fashion. On behalf of the Scientific Committee, you are invited to Tromsø and the BIOPROSP Conference 2011.
The focus in the 2011 conference will be industrial biotech and bioprospecting as a stepping stone towards the bioeconomy.
Target group: Academic and industry researchers, decision makers, regulatory experts, investors and public facilitators.
19 2010
Ongoing Project Aims to Recover Nutritional Value From Seafood and Brewing Waste
Preliminary findings from a UK government funded project focused on extracting value from seafood and beverage processing waste shows the process could potentially recover nutritional components such as glucosamine.
The process involves an ionic liquid (IL) extraction process which selectively recovers targeted high value components under mild conditions. Ionic Liquids are clean, inexpensive solvents whose properties can be tailored for recovery of specific target molecules. Recycling of recovered components for applications in pharmaceutical, nutraceutical and chemical markets will deliver both economic and environmental benefits to technology adopters.
C-Tech Innovation, a UK based technology development company, is leading the three year EXCIL project that involves collaboration with key stakeholders including Heineken UK, seafood processor West Coast Sea Products, GlycoMar Ltd., the Sea Fish Industry Authority, waste management firm SITA UK and Imperial College London.
The research is being by funded by a UK government agency, the Technology Strategy Board, with the stated objective being to provide a new approach to solving the environmental and financial costs involved in disposal of food and brewing waste through a sustainable and resource efficient method.
EXCIL is a 3 year project which started in October 2009.
17 2010
Aqua Bio Tech Signs Major Supply Development Agreements
Aqua Bio Technology ASA (ABT), a marine biotechnology and ingredient company, signed two major supply and development agreements. The first agreement is with Bioforskning AS to supply ABT’s patented bioactive ingredient Zonase X™, an ingredient with origins from salmon hatching fluid for use in Bioforskning’s Skin Science professional skincare line. ABT has also secured a major supply and development deal with a global market leader in the health care sector.
Biofoskning’s Skin Science is an exclusive skincare line sold in the Scandinavian professional skincare market. Bioforskning AS is currently preparing a sales expansion of their Skin Science line to several major European markets during the second half of 2010, in addition to developing new lines of products incorporating ingredients such as ABT’s Zonase X, which will be launched during the second half of 2010 and first half 2011.
ABT’s supply and development agreement with the global health care company, who does not wish to be disclosed at this time for strategic reasons, involves development of new products based on certain components contained in ABT’s patented Zonase technology, including Zonase X. The agreement represents a breakthrough for ABT’s new ingredient technology and has significant commercial potential for the company, as it comprises development of products outside of the original application areas of Zonase (which include exfoliation, moisturization and rejuvenation of skin), proving the versatility of the Zonase X technology. A patent application has been filed securing both parties’ common commercial rights within the new product area.
14 2010
Final Program Available for Marine Biodiscovery Event in the UK, June 2010
This meeting, coinciding with the opening of the new £1.6M Marine Biodiscovery Centre, will address the potential for new products and processes from the marine environment, with a particular emphasis on the technical challenges and realising successful outcomes. This will cover novel pharmaceuticals and high value chemicals such as biomaterials, nutraceuticals and personal care products as well as novel enzymes with unique activities. Academic and industrial aspects will be presented and there will be a showcase for Scottish companies and facilities.
06 2010
Marine Ingredients Poised For Accelerated Development
Inside Cosmeceuticals posted an editorial feature we recently wrote on the future for Marine Ingredients. Read more below:
————————
Many believe the ocean is where life first started. Then it is no surprise, perhaps, that the biggest potential source for new, bioactive ingredients for the health and beauty market may originate from the same place. With so many new species of marine life still to be discovered, the potential for new marine-derived compounds and extracts is immense, and the industry is poised for accelerated development in the near future.
Later this year, the final results of the Census of Marine Life will be revealed. This 10-year ambitious initiative, driven by a global network of researchers in about 80 nations, is intended to assess and explain the diversity, distribution and abundance of marine life in the world’s oceans. This massive study will tell us about newly identified marine organisms and marine life not previously known. This news is exciting, as new promising bacteria, organisms and compounds will be likely discovered, providing a potential treasure trove of new marine ingredient products.
29 2010
Blue Moon Marine Botanicals introduces red algae-based AlgalAid, external analgesic for treatment of cold sores and fever blisters.
Blue Moon Marine Botanicals recently introduced AlgalAid, an FDA-monograph compliant external analgesic for the treatment of cold sores and fever blisters. Each batch contains whole-plant extracts of Alaskan marine red algae whose anti-viral efficacy is measured and incorporated in AlgalAid to provide 10 times the concentration needed to inhibit 90 percent of a reference herpes simplex (HSV)1 virus in-vitro.
30 2010
Norwegian natural marine ingredient set to revolutionize anti-aging market
The new marine ingredient offers multiple applications including gentle exfoliation and moisturizing, shown to accelerate new skin cell growth.
Aqua Bio Technology AS (ABT), a Norwegian marine biotechnology company developing innovative active ingredients for the global personal care industry, today announced the global launch of ZONASE X™, a natural anti-aging ingredient composed of marine peptides and unique, non-toxic marine enzymes. Following successful launch in the highly demanding Scandinavian market, ZONASE X™ is now ready for the global market.
The primary benefit of the unique ZONASE X is gentle, yet effective exfoliation, making it a safe and natural alternative to α-hydroxy acid, harsh fruit enzyme peels, and other potentially caustic exfoliating agents. In addition, the ingredient has shown excellent moisturizing properties, allowing for accelerated skin cell growth. “The anti-aging category is driving the market, with forecasts of double-digit growth over the next five years,” said Thor Arne Talseth, Executive Chairman. “Our testing shows that all-natural ZONASE X is as effective as other exfoliants on the market – yet does not have the same abrasive qualities and is far gentler on the skin. It also offers a moisturizing benefit, providing additional value. These positive attributes have been very well-received during Scandinavian launch, and we believe this unique discovery could quickly become a dominant ingredient within the anti-aging segment.”
ZONASE X was first discovered at the salmon fish hatcheries in Norway, where hatchery staff members had surprisingly smooth hands – despite being immersed in intensely cold water for long periods. Their smooth skin was in fact due to an enzyme in the water secreted by fish larvae inside the egg just prior to hatching. This enzyme helps to break the egg shell during hatching — without harming the highly fragile larvae inside. Further research on this new enzyme indicated that the egg shell had a protein structure akin to corneum proteins of human skin. Thus, the connection to the smooth hands was made – and a new, natural and gentle exfoliant was discovered.
22 2010
Rousselot launches anti-aging marine collagen peptide
As a major international player within the hydrolyzed collagen industry, Rousselot, produces and markets its hydrolyzed collagens to the health and nutricosmetic industries. Recently the Group announced a new Peptan™ Cosmetic range intended for cosmetic applications. Supported by recent studies, Rousselot is launching PeptanTM SR marine (Skin Regeneration) and Peptan™ MR marine (Moisture Retention), topical versions of the Rousselot nutricosmetic active principle.
22 2010
BioMarine Fuels of Florida selected to present at CleanEquity Monaco 2010
BioMarine Fuels has been selected to present at CleanEquity Monaco 2010, the foremost event for next generation clean and green technology next month. The algal fuels pioneer is a development-stage company focused on the production of algal biomass in a patent-pending, closed photobioreactor system, or SolarMagnatron™. Products include the creation of “green” biofuels for the electric power and transportation fuels industry, and valuable chemicals like Omega 3 oil used in the pharmaceutical, nutraceutical and food products.
They intend to combine with identified new technologies that will also enable our company to neutralize fossil fueled smokestack pollution while capturing the waste CO2 and converting the discharged pollutant chemicals into algae nutrients and feedstock for the production of energy-rich algal biomass within the SolarMagnatron ™ bioreactor system.
22 2010
Marine Biodiscovery: Research & Applications Meeting; 15-16 June 2010 – University of Aberdeen, Scotland, UK
This meeting, coinciding with the opening of the new £1.6M Marine Biodiscovery Centre, will address the potential for new products and processes from the marine environment, with a particular emphasis on the technical challenges and realising successful outcomes. This will cover novel pharmaceuticals and high value chemicals such as biomaterials, nutraceuticals and personal care products as well as novel enzymes with unique activities. Academic and industrial aspects will be presented and there will be a showcase for Scottish companies and facilities.
Topics:
- Accessing and assessing marine biodiversity
- Molecular methods to find and express secondary metabolites and enzymes.
- Extraction and isolation of small molecules & modern methods for structural characterisation
- Marine bioinorganic chemistry
- Screening marine natural products
- Applications in the nutraceuticals and personal care market.
- Applications in the high value markets for instance pharmaceuticals and enzymes.
- Taking marine pharmaceuticals to the market
- Marine biomaterials
RSS Feed 
Search
News Archive
Categories
Host
 |
Partners
 |
Sponsors
 |  |
Latest News
- Researchers worry that damage to the oceans could mean some species — and whatever chemicals they produce — will be lost before they’re found
- Neptune Technologies & Bioressources profits rise on krill oil success
- Shellfish Waste May Give Us “Vanishing Plastic”
- Solazyme Delivers 100% Algal-Derived Renewable Jet Fuel to U.S. Navy
- MDPI Publishes New Marine Drugs Issue: Volume 8, Issue 6
Recent Comments
- Константин on Aquapharm completes £4.2 million investment
- Арсений on MOU signed between Universiti Sains Malaysia (USM) and the Rheinische-Friedrich-Wilhelms University in Bonn, Germany, On Marine Biotech Development
- Валентин on Blue Bio Open Innovation (BBOI): Norway and Sweden Collaborate on Joint Marine Biotech Development
- Коля on MOU signed between Universiti Sains Malaysia (USM) and the Rheinische-Friedrich-Wilhelms University in Bonn, Germany, On Marine Biotech Development
- Olha on GRC hosts Marine Natural Products conference in California, Feb 2010
Share Aquapreneur
